Dustin Thompson
Primary Care · Layton, UTNPI 1609452960
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,507 of the $6,023 with a category attached, or 74.8%. 47 manufacturers reported payments, led by Medtronic at 32.7% of the total. 2025 is the largest year on record at $3,390, more than ten times the $232 reported in 2021. Among primary care clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 230 payments — averaging $26.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Sanofi-aventis U.S. LLC$449
- Corcept Therapeutics$412
- AbbVie$346
- Amgen$303
- Lilly USA, LLC$281
- plus $2K from 41 others
What the payments were for
- Travel & lodging$1,51625%
- Food & beverage$4,50775%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$1,575
- Omnipod$135
- TZIELD$127
- EVENITY$122
- Korlym$113
How this compares
$6,023 in reported general payments places this provider in the 90th percentile of 60 primary care providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 11 | $1,308 |
| Levothyroxine Sodium | 46 | $550 |
| Omeprazole | 32 | $502 |
| Duloxetine Hcl | 21 | $485 |
| Metformin Hcl | 25 | $299 |
| Lisinopril | 25 | $214 |
| Gabapentin | 11 | $210 |
| Amlodipine Besylate | 29 | $209 |
| Allopurinol | 15 | $185 |
| Clonazepam | 18 | $184 |
| Fluticasone Propionate | 16 | $146 |
| Escitalopram Oxalate | 18 | $144 |
| Losartan Potassium | 13 | $142 |
| Simvastatin | 20 | $141 |
| Donepezil Hcl | 12 | $134 |
Paid to pharmacies, not to this prescriber.
Other primary care in Layton
- London JacksonSpringville$22K
- Tyler HobbsProvo$15K
- Jeffrey WalshBountiful$15K
- Marcella RowleyRiverton$13K
- Elizabeth WillmoreRiverton$6K
- Catherine CoatesSalt Lake City$5K
- Liana KinikiniWest Jordan$4K
- Stacey LakeHolladay$3K
- Madeleine RupertSalt Lake City$3K
- Holly WortleyBountiful$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.